Pharma Focus Asia

RubrYc Therapeutics Announces Research Collaboration and Licensing Option Agreement with Zai Labs

Saturday, April 17, 2021

RubrYc Therapeutics, Inc., a company that manufactures preclinical biotherapeutic products and develops epitope-selective therapies,announced that it has entered into a research collaboration and licensing option agreement with Zai Labs. on the use of RubrYc's Meso-scale Engineered Molecules (MEMs) platform to identify monoclonal antibodies with enhanced biological function for previously unpublished oncology purposes.

Under the agreement, RubrYc and Zai Labs will work together to identify product candidates using the RubrYc discovery engine. The discovery engine uses machine learning and uses structural data to identify antibodies that bind to subdominant epitopes and show differentiated activity. The license option grants Zai Labs the exclusive global right to develop and commercially deploy the product (s) discovered in the research collaboration.

RubrYc Therapeutics, Inc. is entitled to a prepayment amount and, for each drug candidate, to meet any additional fees and license fees for achieving net research, development and commercial launch milestones after net sales of each product globally. The financial terms of the agreement were not disclosed.

Dr. Isaac Bright, CEO of RubrYc, said: “We are very pleased that Zai Labs has selected the RubrYc discovery engine for its work to identify biotherapeutic agents for the highly challenging oncological diseases. We look forward to working with Zai Labs to accelerate their research to identify epitope-specific antibodies with differentiated mechanisms of action. Zai Labs' oncology expertise complements our efforts to provide new breakthrough therapies to patients in need. ”

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024